跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TACHOSIL
Authorized
STANDARD
TACHOSIL
Corza Medical GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c77c3a411f1d41c7
Company
Corza Medical GmbH
Type
Standard
Approval Details
Approval Id
c77c3a411f1d41c7
Drug Approval Canada Name
TACHOSIL
Product Name
TACHOSIL
Status
Approved
Status Date
2022-02-25
Din
02439026
Drug Class
Human
Dosage Form
Patch
Route Of Administration
Topical
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BC30 COMBINATIONS
Atc Name
b 02 bc 30
Aig Number
0356730001
Company Name
Corza Medical GmbH
Company Address
21 Speditionsstrasse, Dusseldorf, Nordrhein-Westfalen, Germany, 40221
Company Detail Path
/organization/corza-medical-gmbh
Company Information
Pharmaceutical Company Name
Corza Medical GmbH
Country Name
Switzerland
Website
https://corza.com
Active Ingredients
FIBRINOGEN (HUMAN)
5.5 MG / SQ CM
COLLAGEN
2.1 MG / SQ CM
THROMBIN (HUMAN)
2 UNIT / SQ CM
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c77c3a411f1d41c7
Type
Standard
Back to Health Canada Approvals
TACHOSIL - Health Canada Drug Approval Details